Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 264

1.

Insight on mutation-induced resistance to anaplastic lymphoma kinase inhibitor ceritinib from molecular dynamics simulations.

He MY, Li WK, Meiler J, Zheng QC, Zhang HX.

Biopolymers. 2019 Jan 21:e23257. doi: 10.1002/bip.23257. [Epub ahead of print]

PMID:
30664251
2.

Multistate design of influenza antibodies improves affinity and breadth against seasonal viruses.

Sevy AM, Wu NC, Gilchuk IM, Parrish EH, Burger S, Yousif D, Nagel MBM, Schey KL, Wilson IA, Crowe JE Jr, Meiler J.

Proc Natl Acad Sci U S A. 2019 Jan 14. pii: 201806004. doi: 10.1073/pnas.1806004116. [Epub ahead of print]

3.

Modeling the complete chemokine-receptor interaction.

Wedemeyer MJ, Mueller BK, Bender BJ, Meiler J, Volkman BF.

Methods Cell Biol. 2019;149:289-314. doi: 10.1016/bs.mcb.2018.09.005. Epub 2018 Nov 1.

PMID:
30616825
4.

High-Throughput Functional Evaluation of KCNQ1 Decrypts Variants of Unknown Significance.

Vanoye CG, Desai RR, Fabre KL, Gallagher SL, Potet F, DeKeyser JM, Macaya D, Meiler J, Sanders CR, George AL Jr.

Circ Genom Precis Med. 2018 Nov;11(11):e002345. doi: 10.1161/CIRCGEN.118.002345.

PMID:
30571187
5.

Contribution of Cotranslational Folding Defects to Membrane Protein Homeostasis.

Roushar FJ, Gruenhagen TC, Penn WD, Li B, Meiler J, Jastrzebska B, Schlebach JP.

J Am Chem Soc. 2018 Dec 11. doi: 10.1021/jacs.8b08243. [Epub ahead of print]

PMID:
30537820
6.

Mono(2-ethylhexyl) phthalate (MEHP) and mono(2-ethyl-5-oxohexyl) phthalate (MEOHP) but not di(2-ethylhexyl) phthalate (DEHP) bind productively to the peroxisome proliferator-activated receptor γ.

Kratochvil I, Hofmann T, Rother S, Schlichting R, Moretti R, Scharnweber D, Hintze V, Escher BI, Meiler J, Kalkhof S, von Bergen M.

Rapid Commun Mass Spectrom. 2018 Aug 7. doi: 10.1002/rcm.8258. [Epub ahead of print]

PMID:
30085373
7.

LBA-008Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) as perioperative treatment of resectable gastric or gastro-esophageal junction adenocarcinoma: The multicenter, randomized phase 3 FLOT4 trial (German Gastric Group at AIO).

Al-Batran SE, Pauligk C, Homann N, Schmalenberg H, Kopp HG, Haag GM, Luley Kim B, Schmiegel Wolff H, Folprecht G, Probst S, Prasnikar N, Thuss-Patience Peter C, Trojan J, Goetze TO, Meiler J, Schuler Martin H, Jäger E, Hofheinz RD.

Ann Oncol. 2017 Jun 1;28(suppl_3). doi: 10.1093/annonc/mdx302.007. No abstract available.

PMID:
30052790
8.

Pharmacological evaluation of new constituents of "Spice": synthetic cannabinoids based on indole, indazole, benzimidazole and carbazole scaffolds.

Schoeder CT, Hess C, Madea B, Meiler J, Müller CE.

Forensic Toxicol. 2018;36(2):385-403. doi: 10.1007/s11419-018-0415-z. Epub 2018 Apr 26.

9.

Discovery, Characterization, and Effects on Renal Fluid and Electrolyte Excretion of the Kir4.1 Potassium Channel Pore Blocker, VU0134992.

Kharade SV, Kurata H, Bender AM, Blobaum AL, Figueroa EE, Duran A, Kramer M, Days E, Vinson P, Flores D, Satlin LM, Meiler J, Weaver CD, Lindsley CW, Hopkins CR, Denton JS.

Mol Pharmacol. 2018 Aug;94(2):926-937. doi: 10.1124/mol.118.112359. Epub 2018 Jun 12.

PMID:
29895592
10.

Structure and Function of the Transmembrane Domain of NsaS, an Antibiotic Sensing Histidine Kinase in Staphylococcus aureus.

Bhate MP, Lemmin T, Kuenze G, Mensa B, Ganguly S, Peters JM, Schmidt N, Pelton JG, Gross CA, Meiler J, DeGrado WF.

J Am Chem Soc. 2018 Jun 20;140(24):7471-7485. doi: 10.1021/jacs.7b09670. Epub 2018 Jun 9.

PMID:
29771498
11.

RosettaLigandEnsemble: A Small-Molecule Ensemble-Driven Docking Approach.

Fu DY, Meiler J.

ACS Omega. 2018 Apr 30;3(4):3655-3664. doi: 10.1021/acsomega.7b02059. Epub 2018 Apr 2.

12.

Structural basis of ligand binding modes at the neuropeptide Y Y1 receptor.

Yang Z, Han S, Keller M, Kaiser A, Bender BJ, Bosse M, Burkert K, Kögler LM, Wifling D, Bernhardt G, Plank N, Littmann T, Schmidt P, Yi C, Li B, Ye S, Zhang R, Xu B, Larhammar D, Stevens RC, Huster D, Meiler J, Zhao Q, Beck-Sickinger AG, Buschauer A, Wu B.

Nature. 2018 Apr;556(7702):520-524. doi: 10.1038/s41586-018-0046-x. Epub 2018 Apr 18.

13.

Tracing the evolution of the heterotrimeric G protein α subunit in Metazoa.

Lokits AD, Indrischek H, Meiler J, Hamm HE, Stadler PF.

BMC Evol Biol. 2018 Apr 11;18(1):51. doi: 10.1186/s12862-018-1147-8.

14.

Holistic Approach to Partial Covalent Interactions in Protein Structure Prediction and Design with Rosetta.

Combs SA, Mueller BK, Meiler J.

J Chem Inf Model. 2018 May 29;58(5):1021-1036. doi: 10.1021/acs.jcim.7b00398. Epub 2018 Apr 19.

PMID:
29641200
15.

α2A- and α2C-Adrenoceptors as Potential Targets for Dopamine and Dopamine Receptor Ligands.

Sánchez-Soto M, Casadó-Anguera V, Yano H, Bender BJ, Cai NS, Moreno E, Canela EI, Cortés A, Meiler J, Casadó V, Ferré S.

Mol Neurobiol. 2018 Nov;55(11):8438-8454. doi: 10.1007/s12035-018-1004-1. Epub 2018 Mar 18.

PMID:
29552726
16.

Mechanisms of KCNQ1 channel dysfunction in long QT syndrome involving voltage sensor domain mutations.

Huang H, Kuenze G, Smith JA, Taylor KC, Duran AM, Hadziselimovic A, Meiler J, Vanoye CG, George AL Jr, Sanders CR.

Sci Adv. 2018 Mar 7;4(3):eaar2631. doi: 10.1126/sciadv.aar2631. eCollection 2018 Mar.

17.

Integrated Structural Biology for α-Helical Membrane Protein Structure Determination.

Xia Y, Fischer AW, Teixeira P, Weiner B, Meiler J.

Structure. 2018 Apr 3;26(4):657-666.e2. doi: 10.1016/j.str.2018.02.006. Epub 2018 Mar 8.

PMID:
29526436
18.

Comprehensive Analysis of Constraint on the Spatial Distribution of Missense Variants in Human Protein Structures.

Sivley RM, Dou X, Meiler J, Bush WS, Capra JA.

Am J Hum Genet. 2018 Mar 1;102(3):415-426. doi: 10.1016/j.ajhg.2018.01.017. Epub 2018 Feb 15.

19.

Integrating linear optimization with structural modeling to increase HIV neutralization breadth.

Sevy AM, Panda S, Crowe JE Jr, Meiler J, Vorobeychik Y.

PLoS Comput Biol. 2018 Feb 16;14(2):e1005999. doi: 10.1371/journal.pcbi.1005999. eCollection 2018 Feb.

20.

Improved in Vitro Folding of the Y2 G Protein-Coupled Receptor into Bicelles.

Schmidt P, Bender BJ, Kaiser A, Gulati K, Scheidt HA, Hamm HE, Meiler J, Beck-Sickinger AG, Huster D.

Front Mol Biosci. 2018 Jan 17;4:100. doi: 10.3389/fmolb.2017.00100. eCollection 2017.

21.

Three-dimensional spatial analysis of missense variants in RTEL1 identifies pathogenic variants in patients with Familial Interstitial Pneumonia.

Sivley RM, Sheehan JH, Kropski JA, Cogan J, Blackwell TS, Phillips JA, Bush WS, Meiler J, Capra JA.

BMC Bioinformatics. 2018 Jan 23;19(1):18. doi: 10.1186/s12859-018-2010-z.

22.

The molecular basis of subtype selectivity of human kinin G-protein-coupled receptors.

Joedicke L, Mao J, Kuenze G, Reinhart C, Kalavacherla T, Jonker HRA, Richter C, Schwalbe H, Meiler J, Preu J, Michel H, Glaubitz C.

Nat Chem Biol. 2018 Mar;14(3):284-290. doi: 10.1038/nchembio.2551. Epub 2018 Jan 15.

PMID:
29334381
23.

The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding.

King LB, Fusco ML, Flyak AI, Ilinykh PA, Huang K, Gunn B, Kirchdoerfer RN, Hastie KM, Sangha AK, Meiler J, Alter G, Bukreyev A, Crowe JE Jr, Saphire EO.

Cell Host Microbe. 2018 Jan 10;23(1):101-109.e4. doi: 10.1016/j.chom.2017.12.003.

24.

Identification of a ubiquitin-binding interface using Rosetta and DEER.

Tessmer MH, Anderson DM, Pickrum AM, Riegert MO, Moretti R, Meiler J, Feix JB, Frank DW.

Proc Natl Acad Sci U S A. 2018 Jan 16;115(3):525-530. doi: 10.1073/pnas.1716861115. Epub 2018 Jan 2.

25.

Predictive Power of Different Types of Experimental Restraints in Small Molecule Docking: A Review.

Fu DY, Meiler J.

J Chem Inf Model. 2018 Feb 26;58(2):225-233. doi: 10.1021/acs.jcim.7b00418. Epub 2018 Jan 18.

PMID:
29286651
26.

PIK3CA C2 Domain Deletions Hyperactivate Phosphoinositide 3-kinase (PI3K), Generate Oncogene Dependence, and Are Exquisitely Sensitive to PI3Kα Inhibitors.

Croessmann S, Sheehan JH, Lee KM, Sliwoski G, He J, Nagy R, Riddle D, Mayer IA, Balko JM, Lanman R, Miller VA, Cantley LC, Meiler J, Arteaga CL.

Clin Cancer Res. 2018 Mar 15;24(6):1426-1435. doi: 10.1158/1078-0432.CCR-17-2141. Epub 2017 Dec 28.

PMID:
29284706
27.

Development of Erasin: a chromone-based STAT3 inhibitor which induces apoptosis in Erlotinib-resistant lung cancer cells.

Lis C, Rubner S, Roatsch M, Berg A, Gilcrest T, Fu D, Nguyen E, Schmidt AM, Krautscheid H, Meiler J, Berg T.

Sci Rep. 2017 Dec 12;7(1):17390. doi: 10.1038/s41598-017-17600-x.

28.

Consensus queries in ligand-based virtual screening experiments.

Berenger F, Vu O, Meiler J.

J Cheminform. 2017 Nov 28;9(1):60. doi: 10.1186/s13321-017-0248-5.

29.

Role of Non-local Interactions between CDR Loops in Binding Affinity of MR78 Antibody to Marburg Virus Glycoprotein.

Sangha AK, Dong J, Williamson L, Hashiguchi T, Saphire EO, Crowe JE Jr, Meiler J.

Structure. 2017 Dec 5;25(12):1820-1828.e2. doi: 10.1016/j.str.2017.10.005. Epub 2017 Nov 16.

30.

Computational design of membrane proteins using RosettaMembrane.

Duran AM, Meiler J.

Protein Sci. 2018 Jan;27(1):341-355. doi: 10.1002/pro.3335. Epub 2017 Nov 15.

31.

Predicting the Functional Impact of KCNQ1 Variants of Unknown Significance.

Li B, Mendenhall JL, Kroncke BM, Taylor KC, Huang H, Smith DK, Vanoye CG, Blume JD, George AL Jr, Sanders CR, Meiler J.

Circ Cardiovasc Genet. 2017 Oct;10(5). pii: e001754. doi: 10.1161/CIRCGENETICS.117.001754.

32.

Finding the needle in the haystack: towards solving the protein-folding problem computationally.

Li B, Fooksa M, Heinze S, Meiler J.

Crit Rev Biochem Mol Biol. 2018 Feb;53(1):1-28. doi: 10.1080/10409238.2017.1380596. Epub 2017 Oct 4. Review.

PMID:
28976219
33.

Web-accessible molecular modeling with Rosetta: The Rosetta Online Server that Includes Everyone (ROSIE).

Moretti R, Lyskov S, Das R, Meiler J, Gray JJ.

Protein Sci. 2018 Jan;27(1):259-268. doi: 10.1002/pro.3313. Epub 2017 Oct 27.

34.

Quantitative Structure-Activity Relationship Modeling of Kinase Selectivity Profiles.

Kothiwale S, Borza C, Pozzi A, Meiler J.

Molecules. 2017 Sep 19;22(9). pii: E1576. doi: 10.3390/molecules22091576.

35.

Carbon and amide detect backbone assignment methods of a novel repeat protein from the staphylocoagulase in S. aureus.

Voehler M, Ashoka MA, Meiler J, Bock PE.

Biomol NMR Assign. 2017 Oct;11(2):243-249. doi: 10.1007/s12104-017-9757-4. Epub 2017 Aug 17.

36.

Identification and Characterization of the First Selective Y4 Receptor Positive Allosteric Modulator.

Schubert M, Stichel J, Du Y, Tough IR, Sliwoski G, Meiler J, Cox HM, Weaver CD, Beck-Sickinger AG.

J Med Chem. 2017 Sep 14;60(17):7605-7612. doi: 10.1021/acs.jmedchem.7b00976. Epub 2017 Aug 28.

PMID:
28795803
37.

Structure and Dynamics of Type III Secretion Effector Protein ExoU As determined by SDSL-EPR Spectroscopy in Conjunction with De Novo Protein Folding.

Fischer AW, Anderson DM, Tessmer MH, Frank DW, Feix JB, Meiler J.

ACS Omega. 2017 Jun 30;2(6):2977-2984. doi: 10.1021/acsomega.7b00349. Epub 2017 Jun 27.

38.

Pore Polarity and Charge Determine Differential Block of Kir1.1 and Kir7.1 Potassium Channels by Small-Molecule Inhibitor VU590.

Kharade SV, Sheehan JH, Figueroa EE, Meiler J, Denton JS.

Mol Pharmacol. 2017 Sep;92(3):338-346. doi: 10.1124/mol.117.108472. Epub 2017 Jun 15.

39.

Membrane protein contact and structure prediction using co-evolution in conjunction with machine learning.

Teixeira PL, Mendenhall JL, Heinze S, Weiner B, Skwark MJ, Meiler J.

PLoS One. 2017 May 24;12(5):e0177866. doi: 10.1371/journal.pone.0177866. eCollection 2017.

40.

Prostaglandin E2 glyceryl ester is an endogenous agonist of the nucleotide receptor P2Y6.

Brüser A, Zimmermann A, Crews BC, Sliwoski G, Meiler J, König GM, Kostenis E, Lede V, Marnett LJ, Schöneberg T.

Sci Rep. 2017 May 24;7(1):2380. doi: 10.1038/s41598-017-02414-8.

41.

Molecular dissection of effector mechanisms of RAS-mediated resistance to anti-EGFR antibody therapy.

Kasper S, Reis H, Ziegler S, Nothdurft S, Mueller A, Goetz M, Wiesweg M, Phasue J, Ting S, Wieczorek S, Even A, Worm K, Pogorzelski M, Breitenbuecher S, Meiler J, Paul A, Trarbach T, Schmid KW, Breitenbuecher F, Schuler M.

Oncotarget. 2017 Jul 11;8(28):45898-45917. doi: 10.18632/oncotarget.17438.

42.

An Acquired HER2T798I Gatekeeper Mutation Induces Resistance to Neratinib in a Patient with HER2 Mutant-Driven Breast Cancer.

Hanker AB, Brewer MR, Sheehan JH, Koch JP, Sliwoski GR, Nagy R, Lanman R, Berger MF, Hyman DM, Solit DB, He J, Miller V, Cutler RE Jr, Lalani AS, Cross D, Lovly CM, Meiler J, Arteaga CL.

Cancer Discov. 2017 Jun;7(6):575-585. doi: 10.1158/2159-8290.CD-16-1431. Epub 2017 Mar 8.

43.

Improving prediction of helix-helix packing in membrane proteins using predicted contact numbers as restraints.

Li B, Mendenhall J, Nguyen ED, Weiner BE, Fischer AW, Meiler J.

Proteins. 2017 Jul;85(7):1212-1221. doi: 10.1002/prot.25281. Epub 2017 Apr 1.

44.

High-Throughput Screening Assay Datasets from the PubChem Database.

Butkiewicz M, Wang Y, Bryant SH, Lowe EW Jr, Weaver DC, Meiler J.

Chem Inform. 2017;3(1). pii: 1. Epub 2017 Apr 26.

45.

Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis.

Borza CM, Su Y, Tran TL, Yu L, Steyns N, Temple KJ, Skwark MJ, Meiler J, Lindsley CW, Hicks BR, Leitinger B, Zent R, Pozzi A.

Matrix Biol. 2017 Jan;57-58:258-271. doi: 10.1016/j.matbio.2016.11.009. Epub 2016 Dec 1.

46.

A Deep Hydrophobic Binding Cavity is the Main Interaction for Different Y2 R Antagonists.

Burkert K, Zellmann T, Meier R, Kaiser A, Stichel J, Meiler J, Mittapalli GK, Roberts E, Beck-Sickinger AG.

ChemMedChem. 2017 Jan 5;12(1):75-85. doi: 10.1002/cmdc.201600433. Epub 2016 Nov 30.

PMID:
27874262
47.

Evaluation of TSPO PET Ligands [18F]VUIIS1009A and [18F]VUIIS1009B: Tracers for Cancer Imaging.

Tang D, Li J, Buck JR, Tantawy MN, Xia Y, Harp JM, Nickels ML, Meiler J, Manning HC.

Mol Imaging Biol. 2017 Aug;19(4):578-588. doi: 10.1007/s11307-016-1027-9.

48.

Structural basis for nonneutralizing antibody competition at antigenic site II of the respiratory syncytial virus fusion protein.

Mousa JJ, Sauer MF, Sevy AM, Finn JA, Bates JT, Alvarado G, King HG, Loerinc LB, Fong RH, Doranz BJ, Correia BE, Kalyuzhniy O, Wen X, Jardetzky TS, Schief WR, Ohi MD, Meiler J, Crowe JE Jr.

Proc Natl Acad Sci U S A. 2016 Nov 1;113(44):E6849-E6858. Epub 2016 Oct 17.

49.

Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial.

Al-Batran SE, Hofheinz RD, Pauligk C, Kopp HG, Haag GM, Luley KB, Meiler J, Homann N, Lorenzen S, Schmalenberg H, Probst S, Koenigsmann M, Egger M, Prasnikar N, Caca K, Trojan J, Martens UM, Block A, Fischbach W, Mahlberg R, Clemens M, Illerhaus G, Zirlik K, Behringer DM, Schmiegel W, Pohl M, Heike M, Ronellenfitsch U, Schuler M, Bechstein WO, Königsrainer A, Gaiser T, Schirmacher P, Hozaeel W, Reichart A, Goetze TO, Sievert M, Jäger E, Mönig S, Tannapfel A.

Lancet Oncol. 2016 Dec;17(12):1697-1708. doi: 10.1016/S1470-2045(16)30531-9. Epub 2016 Oct 22.

PMID:
27776843
50.

Structural basis for KCNE3 modulation of potassium recycling in epithelia.

Kroncke BM, Van Horn WD, Smith J, Kang C, Welch RC, Song Y, Nannemann DP, Taylor KC, Sisco NJ, George AL Jr, Meiler J, Vanoye CG, Sanders CR.

Sci Adv. 2016 Sep 9;2(9):e1501228. doi: 10.1126/sciadv.1501228. eCollection 2016 Sep.

Supplemental Content

Loading ...
Support Center